STAAR Surgical
STAA
207 hedge funds and large institutions have $1.62B invested in STAAR Surgical in 2023 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 57 increasing their positions, 90 reducing their positions, and 36 closing their positions.
4.08% less ownership
Funds ownership: 110.13% → 106.06% (-4.1%)
5% less funds holding
Funds holding: 217 → 207 (-10)
12% less call options, than puts
Call options by funds: $12.1M | Put options by funds: $13.8M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
25% less capital invested
Capital invested by funds: $2.15B → $1.62B (-$533M)
25% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 36
37% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 90
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadwood Capital
New York
|
+$45.8M |
| 2 |
Morgan Stanley
New York
|
+$17M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$14.6M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$10.1M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.56M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Anatole Investment Management
Central,
Hong Kong
|
-$51.6M |
| 2 |
EFM
E Fund Management
Guangzhou,
China
|
-$23.4M |
| 3 |
ClearBridge Investments
New York
|
-$21.7M |
| 4 |
Goldman Sachs
New York
|
-$19.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$19.3M |
STAA Hedge Fund Activity: Q4 2023 in Review
207 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2023, worth a combined $1.62B — down 25% from $2.15B a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of STAA and 27 opened new positions — a net loss of 9 holders — while 90 trimmed existing stakes and 57 added.
The largest buyer was Broadwood Capital, adding an estimated $45.8M. The largest seller was Anatole Investment Management, cutting an estimated $51.6M.
- 207 institutional investors held STAAR Surgical (STAA) as of Q4 2023, down from 217 in Q3 2023.
- Funds reported $1.62B of STAAR Surgical stock for Q4 2023, down 25% quarter-over-quarter.
- 27 funds opened new STAAR Surgical positions in Q4 2023 and 36 closed out, a net change of -9 holders.
- The largest STAAR Surgical buyer in Q4 2023 was Broadwood Capital, an estimated $45.8M added.
- The largest STAAR Surgical seller in Q4 2023 was Anatole Investment Management, an estimated $51.6M sold.
Based on aggregated 13F filings for Q4 2023.